We hear from Jonny Acheson and Clare Addison, two healthcare professionals based in England who have decided to step back from their hospital roles during the Covid-19 pandemic, about why the UK’s National Health Service (NHS) will “never be the same again”
How has the Covid-19 pandemic affected you as NHS workers who are living with Parkinson’s?
Clare Addison, surgical matron: It’s changed my role completely. Having Parkinson’s doesn’t mean you have an increased risk of getting Covid-19 but if you do get it, you will likely have a slower recovery path, meaning you could deprive someone else of valuable medical attention. We need to be socially responsible to enable resources for those who need it. So, after hard conversations with my managers, it was clear that I needed to work from home.
It has been challenging for me to accept that I need to step aside from being a healthcare professional and be at home. Being in a senior position, people look up to me for guidance and leadership – so to take myself away from that has been difficult.
Jonny Acheson, A&E consultant: When the guidance came out about people with Parkinson’s having an increased risk, I had to decide what’s best for me as a person with Parkinson’s versus as a trained healthcare professional. Whatever your role is in the NHS, if you are living with Parkinson’s or any high-risk condition, you are torn between what your heart says and what your mind says because you’re trained to deliver a service.
I told my team that someone needs to make this decision for me and that’s what they did.
I’m currently trying to give support from a distance, such as offering telephone support for staff. Team members can ring me whenever they are struggling at work or need to talk. Although we are self-isolating, we’re not cut off from the service and our colleagues. I’ve been drawing some NHS sketches for my team to show my support through pictures as a way of raising morale.
Can you give an insight into how the pandemic is affecting NHS workers?
Jonny: It is unprecedented. We’ve had SARS, swine flu and bird flu, but we’ve never had anything like this before and I don’t think we ever will. There’s anxiety about how quickly this disease gets people and it will unfortunately cause many deaths.
The NHS has gone into a different gear and barriers that were once there are suddenly disappearing. Everyone has gone into the mode of ‘we can do this, we have to do this, and we will do this’. I went to Sainsbury’s supermarket this morning and people were clapping for me. In times of crisis, people really do get behind the NHS.
Clare: There has been a lot of staff refresher training, staff moving to different areas that are in need and adjusting to the new ways of working. What has been incredible is people’s willingness to adapt – you can see they are frightened and anxious but they’re just getting on with it. Covid-19 will change the NHS forever, some of our old and convoluted processes have gone and I don’t see how they will come back. People’s skillsets are going to have been refreshed and broadened.
What would you say to people in the Parkinson’s community that may be struggling physically or emotionally?
Jonny: There is currently an information overload, so if you want to keep up-to-date with coronavirus news, look at vetted sources. I’ve turned notifications off on my devices to give myself some headspace. I don’t think it is helpful to try and predict what is going to happen with Covid-19, instead take each day as it comes and try to live the best you can. Also, keep exercising and make sure you are finding other ways to socialise while socially distancing.
Clare: My mum has Parkinson’s and she told me on a Skype call, “I need you to know that I don’t want to go to hospital, and I am happy to die alone”. That’s a really hard conversation to have with your mother but actually it’s a helpful conversation in some respects because it shows she’s thinking about it.
How does it make you feel to be part of the NHS during this period?
Clare: Massively proud. Although it is frustrating not being in the hospital, we are both doing our bit in other ways. It’s amazing seeing everyone coming together – those who are just starting out, people coming back from retirement and those volunteering. There are definitely struggles to come but there are some positives too.
Jonny: It’s brilliant. This is showing talent and skillsets in workers that we have never seen before, coming out of their shells and becoming leaders. Every time you pick up the badge and see NHS, it feels very symbolic – the NHS won’t be the same again.
Jonny Acheson is an A&E consultant at the University Hospitals of Leicester and works in University of Leicester Medical School in Leicester, UK. Since his Parkinson’s diagnosis in 2016, his role changed from working on the frontline to working mainly in observation wards in the hospital.
Clare Addison is a matron for surgery at Surrey and Sussex Healthcare NHS Trust and is the co-lead of the Parkinson’s UK Excellence Network for the south east of England. Clare was diagnosed with Parkinson’s in 2016 and has a clinical background as a neuroscience specialist nurse.
How have you been affected by the coronavirus?
We will be doing all we can to share useful information about Covid-19 with you as the situation develops – and we need your help. To share your experience or tell us the topics you want Parkinson’s Life to cover during the pandemic, please leave a comment or email email@example.com.
For more information about Parkinson’s and coronavirus please visit the EPDA website.
Meet Julie Dodd, director of digital transformation at Parkinson’s UK
“I know many fantastic female leaders in the charity sector”
4 days ago
Can over-the-counter drugs reduce risk of developing genetic Parkinson’s?
A new study suggests that regular use of non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin and ibuprofen may lower the risk of Parkinson’s associated with mutations of the LRRK2 gene – a common genetic cause of the condition. As part of the study, researchers analysed the data for 577 individuals with the LRRK2 gene mutation. They found that regular use of aspirin and ibuprofen – at least two pills per week for at least six months – was more prevalent in people who did not have Parkinson’s compared to those with the condition. Across the study, the use of NSAIDs corresponded with roughly a 66% decrease in the risk of Parkinson’s. The researchers say that “the results of this study suggest that the regular use of NSAID medication may lower the risk for Parkinson’s among LRRK2 variant carriers … for both ibuprofen and aspirin” but more research will need to be…
US hospital initiative improves on-time administration of Parkinson’s medication
Late or missed doses of Parkinson’s medication in hospitals can lead to longer stays and greater morbidity. To counteract this issue, a team of healthcare professionals in the US launched a project to improve the on-time administration of levodopa to people with Parkinson’s. As part of the initiative – published in the Journal of Parkinson’s Disease – several measures were implemented, including electronic alerts for nurses, stocking automated medication dispensing machines with carbidopa-levodopa products, reporting to nurse unit managers on timeliness of medication administration and more. Dr Martha A Nance, the project’s lead investigator, said: “This project was very rewarding for our team, because of its obvious, immediate, and important impact on patient care. “We have reason to think that timely administration of carbidopa-levodopa may be associated with shorter stays and better outcomes and satisfaction. Anecdotally, patients have reported being surprised and pleased that nurses were reminding them that medication…
Does deep brain stimulation for Parkinson’s increase the risk of dementia?
Researchers in France have found that deep brain stimulation for Parkinson’s may not increase the risk of developing dementia. As part of the study – published by the American Academy of Neurology – researchers identified 175 people with Parkinson’s and an average age of 56, who had deep brain stimulation. The individuals were assessed over a period of 10 years to determine if they had developed dementia. After one year, four individuals had developed dementia. After five years, 142 people from the original group were available for testing, 12 of whom had dementia. After 10 years, 104 people were available for testing, 31 of whom had dementia. Dr Elena Moro, author of the study, said: “These results are very encouraging for people with Parkinson’s and their families that they can take advantage of the benefits of deep brain stimulation without worrying about it increasing the likelihood of developing dementia.”